Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B.

PLoS One. 2012;7(1):e29446. doi: 10.1371/journal.pone.0029446. Epub 2012 Jan 10.

2.

Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.

Zhang X, Yang T, Cao J, Sun J, Dai W, Zhang L.

Microb Pathog. 2016 Jul;96:20-5. doi: 10.1016/j.micpath.2016.04.019. Epub 2016 Apr 29. Review.

PMID:
27133268
3.

OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.

Huang W, Wang S, Yao Y, Xia Y, Yang X, Long Q, Sun W, Liu C, Li Y, Ma Y.

Vaccine. 2015 Aug 26;33(36):4479-85. doi: 10.1016/j.vaccine.2015.07.031. Epub 2015 Jul 21.

PMID:
26207591
4.

Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.

Huang W, Yao Y, Wang S, Xia Y, Yang X, Long Q, Sun W, Liu C, Li Y, Chu X, Bai H, Yao Y, Ma Y.

Sci Rep. 2016 Feb 8;6:20724. doi: 10.1038/srep20724.

5.

Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.

Garg N, Singh R, Shukla G, Capalash N, Sharma P.

Int J Med Microbiol. 2016 Jan;306(1):1-9. doi: 10.1016/j.ijmm.2015.10.005. Epub 2015 Nov 12.

PMID:
26614015
6.

Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.

Huang W, Yao Y, Long Q, Yang X, Sun W, Liu C, Jin X, Li Y, Chu X, Chen B, Ma Y.

PLoS One. 2014 Jun 23;9(6):e100727. doi: 10.1371/journal.pone.0100727. eCollection 2014.

7.

The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.

Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA.

Infect Immun. 2017 Nov 17;85(12). pii: e00591-17. doi: 10.1128/IAI.00591-17. Print 2017 Dec.

PMID:
28947651
8.

Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.

KuoLee R, Harris G, Yan H, Xu HH, Conlan WJ, Patel GB, Chen W.

Vaccine. 2015 Jan 1;33(1):260-7. doi: 10.1016/j.vaccine.2014.02.083. Epub 2014 Mar 31.

PMID:
24699469
9.

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.

McConnell MJ, Pachón J.

Vaccine. 2010 Dec 10;29(1):1-5. doi: 10.1016/j.vaccine.2010.10.052. Epub 2010 Nov 18.

PMID:
21044668
10.

Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.

Badmasti F, Ajdary S, Bouzari S, Fooladi AA, Shahcheraghi F, Siadat SD.

Mol Immunol. 2015 Oct;67(2 Pt B):552-8. doi: 10.1016/j.molimm.2015.07.031. Epub 2015 Aug 12.

PMID:
26277277
11.

Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.

García-Quintanilla M, Pulido MR, Pachón J, McConnell MJ.

PLoS One. 2014 Dec 8;9(12):e114410. doi: 10.1371/journal.pone.0114410. eCollection 2014.

12.

Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.

Ainsworth S, Ketter PM, Yu JJ, Grimm RC, May HC, Cap AP, Chambers JP, Guentzel MN, Arulanandam BP.

Vaccine. 2017 Jun 8;35(26):3387-3394. doi: 10.1016/j.vaccine.2017.05.017. Epub 2017 May 15.

PMID:
28522011
13.

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B.

Vaccine. 2013 Jan 2;31(2):313-8. doi: 10.1016/j.vaccine.2012.11.008. Epub 2012 Nov 12.

14.

Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.

McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J.

Infect Immun. 2011 Jan;79(1):518-26. doi: 10.1128/IAI.00741-10. Epub 2010 Oct 25.

15.

An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.

Shu MH, MatRahim N, NorAmdan N, Pang SP, Hashim SH, Phoon WH, AbuBakar S.

Sci Rep. 2016 Feb 29;6:22332. doi: 10.1038/srep22332.

16.

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

McConnell MJ, Rumbo C, Bou G, Pachón J.

Vaccine. 2011 Aug 5;29(34):5705-10. doi: 10.1016/j.vaccine.2011.06.001. Epub 2011 Jun 14.

PMID:
21679737
17.

Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T.

Infect Immun. 2012 Oct;80(10):3381-8. doi: 10.1128/IAI.06096-11. Epub 2012 Jul 23.

18.

First steps towards a vaccine against Acinetobacter baumannii.

Garcia-Quintanilla M, Pulido MR, McConnell MJ.

Curr Pharm Biotechnol. 2013;14(10):897-902. Review.

PMID:
24372252
19.

Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.

Ni Z, Chen Y, Ong E, He Y.

Int J Mol Sci. 2017 Feb 21;18(2). pii: E458. doi: 10.3390/ijms18020458.

20.

A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.

Yang FL, Lou TC, Kuo SC, Wu WL, Chern J, Lee YT, Chen ST, Zou W, Lin NT, Wu SH.

Vaccine. 2017 Mar 7;35(10):1440-1447. doi: 10.1016/j.vaccine.2017.01.060. Epub 2017 Feb 9.

PMID:
28190743

Supplemental Content

Support Center